• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jacLink to Publisher's site
J Antimicrob Chemother. Nov 2008; 62(5): 929–933.
Published online Aug 27, 2008. doi:  10.1093/jac/dkn334
PMCID: PMC2566517

Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element



Vibrio cholerae O1 from a 2006 outbreak in Accra were commonly resistant to multiple antimicrobials and, in particular, to trimethoprim/sulfamethoxazole, drugs commonly used in the treatment of cholera. We sought to determine the genetic basis for trimethoprim/sulfamethoxazole resistance in outbreak isolates.


Twenty-seven isolates from the outbreak were screened by PCR and sequencing for class 1 and 2 integrons and for the SXT element.


Twenty-one of the 27 isolates examined, all from the Accra metropolitan area, carried both SXT, an integrated chromosomal element, and a class 2 integron bearing dfrA1, sat and aadA1 cassettes. All these isolates had identical random amplification of polymorphic DNA profiles and two of them also carried a class 1 integron.


Most strains characterized carried multiple elements conferring resistance to trimethoprim. This suggests that trimethoprim/sulfamethoxazole should not be used empirically in cholera treatment.

Keywords: trimethoprim resistance, antimicrobial resistance, antibiotic resistance, cholera

Articles from Journal of Antimicrobial Chemotherapy are provided here courtesy of Oxford University Press
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...